Researchers are currently testing out new drugs in clinical trials aimed at reducing the GLP-1 side effects, which are one of the main reasons people say they stop taking GLP-1 medicines
GLP-1 agonists are not indicated for type 1 diabetes
17 Recent advances in pharmacological treatments Sodium-glucose cotransporter-2 inhibitors SGLT-2 inhibitors (empagliflozin and dapagliflozin) are recommended in most people with type 2 diabetes and CKD, given the strong evidence that SGLT-2 inhibitors reduce CKD progression, heart failure and the risk of atherosclerotic CV disease in people with type 2 diabetes and CKD
"When I talk to patients about weight management, I always bring up these other options as well, because some people don't want to use a needle." Older prescription weight loss pills include: Hydrogel ( Plenity ) Naltrexone-bupropion ( Contrave ) Orlistat ( Xenical ) Phentermine (Adipex, Suprenza) Phentermine topiramate (Qsmyia) While the GLP-1 agonists can produce a weight loss of 10% to 20%, the average weight lost with older medications is lower in the range of 5% to 10% of the starting body weight
Regular Follow-Up Appointments: At Set Point, we believe in ongoing care
Any Questions Call: Newport Beach, CA (949) 646-0251 Laguna Hills, CA (949) 362-4560 Rancho Santa Margarita, CA (949) 459-3952 This offer can not be combined with other coupons and specials
